Cardinal Health, Inc.
Healthcare Distribution / Medical DistributionFounded 1971- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
Cardinal Health, Inc.
Company History
Founded 1971 in Dublin, Ohio, United States
Last reviewed: 2025-07-15 · By Swet Parvadiya
Founded in 1971 by Robert D. Walter in Columbus, Ohio as a food wholesaler, Cardinal Health pivoted to pharmaceutical distribution in 1979 and never looked back. Robert D. Walter was 26 years old when he started Cardinal Foods in Columbus, Ohio in 1971, distributing food products to grocery stores.
Robert D. Walter is the founder of Cardinal Health, Inc., establishing the company in 1971 as Cardinal Foods, a food wholesaler serving central Ohio and the Midwest. Born in Columbus, Ohio, in 1945, Walter graduated summa cum laude from Ohio State University and earned an MBA from Harvard Business School. After a brief, unsatisfying stint as an engineer at North American Rockwell, Walter decided to acquire and rehabilitate a mismanaged company in a simple line of business. He returned to Columbus, borrowed $1.3 million, and acquired Consolidated Foods' distribution division in a leveraged buyout. By 1980, he had grown Cardinal Foods tenfold but reached a strategic dead end in the consolidating food distribution industry. Walter pivoted to pharmaceutical distribution in 1979 with the acquisition of Bailey Drug Co. in Zanesville, Ohio, and executed a rapid series of acquisitions throughout the 1980s. He took the company public in 1983 and changed its name to Cardinal Health in 1994. Under his leadership as CEO through 2004, Cardinal grew from a small food distributor into a $50+ billion healthcare conglomerate through dozens of strategic acquisitions. Walter was known as a superb deal-maker who 'sneaked up' on competition and carefully avoided the pitfalls of big-company culture. He received an honorary doctorate from Ohio University in 1997 and the Christopher Columbus Award from the Greater Columbus Chamber of Commerce in 2001.
Robert D. Walter, a 26-year-old Harvard MBA graduate, borrowed $1.3 million to acquire the food-distribution division of Consolidated Foods in a leveraged buyout, establishing Cardinal Foods in Columbus, Ohio. The company was named after Ohio's state bird, the cardinal.
Walter acquired Bailey Drug Co., a pharmaceutical distributor in Zanesville, Ohio, marking Cardinal's entry into pharmaceutical distribution. This pivot was driven by the stagnation of the food distribution business and the rapid growth of pharmaceutical wholesaling.
Cardinal Distribution Inc. completed its initial public offering on the NASDAQ at $1.03 per share, providing capital for continued expansion through acquisitions. The IPO established the foundation for the company's growth from a regional distributor to a national healthcare enterprise.
Cardinal acquired Ellicott Drug, a pharmaceutical distributor in Buffalo, New York, continuing the acquisition-driven expansion strategy that would define the company's growth for decades.
Cardinal sold its remaining food operations to Roundy's Inc., completing the company's transition from a diversified food and drug distributor to a pure-play pharmaceutical distribution company. By this point, Cardinal was the third-largest pharmaceutical wholesaler in the United States.
The company changed its name from Cardinal Distribution to Cardinal Health, reflecting its expanding mission beyond pure distribution into healthcare services, manufacturing, and technology. Revenues exceeded $1 billion by 1991.
Cardinal acquired Medicine Shoppe International, the country's largest franchise of retail pharmacies, marking the company's first significant non-distribution acquisition and entry into retail pharmacy.
Cardinal acquired Pyxis Corp., a manufacturer of automated supply and pharmaceutical dispensing systems for hospitals, adding medical technology capabilities to the company's portfolio.
Cardinal acquired Allegiance Healthcare Corp. for approximately $4.4 billion, becoming a major player in the medical-surgical products market and establishing the foundation for what would become the Global Medical Products and Distribution segment.
Cardinal Health and CVS Caremark announced the creation of Red Oak Sourcing, a 50/50 joint venture to form the largest generic pharmaceutical sourcing entity in the United States. The venture began operations in July 2014 with an initial 10-year term.
Cardinal Health lost a major pharmaceutical distribution contract with Walgreens, which shifted its distribution to AmerisourceBergen. The contract had generated $3.3 billion in quarterly revenue. This loss demonstrated the customer concentration risk inherent in pharmaceutical wholesale.
Cardinal Health acquired the Patient Recovery business from Medtronic for $6.1 billion, expanding its medical products portfolio and adding significant scale to the Global Medical Products and Distribution segment.
Cardinal Health announced that its pharmaceutical distribution contracts with OptumRx (UnitedHealth Group's pharmacy benefits subsidiary) would not be renewed upon expiration in June 2024. OptumRx had generated approximately 17% of fiscal 2024 revenue ($38.1 billion), representing one of the largest customer losses in pharmaceutical wholesale history.
Despite the OptumRx revenue headwind, Cardinal Health reported fiscal 2025 revenues of $222.6 billion, GAAP operating earnings of $2.3 billion (up 83%), and net earnings of $1.6 billion (up 83%). The company raised fiscal 2026 non-GAAP EPS guidance to $9.30-$9.50 and announced the acquisition of Solaris Health, the country's leading urology MSO.
Cardinal Health's first acquisition in pharmaceutical distribution, marking the company's pivot from food wholesaling to healthcare. Bailey Drug was a small pharmaceutical distributor in Zanesville, Ohio.
Cardinal Health acquired Allegiance Healthcare to become a major player in the medical-surgical products market, adding manufacturing and distribution capabilities for medical and surgical supplies.
Cardinal Health acquired the Patient Recovery business from Medtronic to expand its medical products portfolio, adding wound care, compression therapy, and patient positioning products.
Cardinal Health acquired ADSG, a leading provider of diabetes supplies and services, to expand its at-Home Solutions business and capitalize on the growing direct-to-patient medical supplies market. ADSG serves approximately 500,000 patients annually.
Cardinal Health acquired ION, a network of community oncology practices, to build its specialty care platform in oncology and create integrated care networks combining drug distribution with practice management.
Cardinal Health acquired a 71% stake in GI Alliance, the largest gastroenterology practice management organization in the United States, to expand its specialty care platform into gastroenterology.
Cardinal Health was founded in 1971 by Robert D. Walter as Cardinal Foods, a food distributor in Columbus, Ohio, before strategically pivoting to pharmaceutical distribution in 1979 through acquisition of Bailey Drug Company. The pharmaceutical pivot proved transformational as healthcare distribution exhibited stronger growth characteristics than food distribution, with Cardinal subsequently divesting food business and concentrating entirely on healthcare. Decades of acquisitions including Pharmaceutical Industries (1980), Lincoln Telephone (1983, later divested), and successive pharmaceutical distribution companies built Cardinal into one of America's largest pharmaceutical distributors. The 1994 acquisition of Medical Industries (medical products manufacturer) added significant medical device and supplies business, creating today's diversified healthcare distribution and medical products company. Robert Walter's strategic vision and aggressive acquisition execution built Cardinal Health from regional food distributor to top-3 US healthcare distributor.
Cardinal Health emerged as one of three dominant US pharmaceutical distributors alongside AmerisourceBergen (now Cencora) and McKesson through 1990s-2000s consolidation, with three companies collectively controlling 90%+ of US pharmaceutical wholesale distribution. The oligopoly structure reflects economics requiring massive scale for efficiency in handling thousands of medications across millions of prescriptions monthly, with operating margins of 1-3% requiring volume scale for absolute profitability. Cardinal's competitive position emerged through acquisition strategy including pharmaceutical distributors and specialty pharmacy operations, plus organic growth from major pharmacy chain contracts. Each Big Three distributor handles approximately $200-280 billion in annual pharmaceutical revenue, with thin margins compensated by enormous volumes. The oligopoly structure has remained stable since 2000s consolidation, with new entrants facing prohibitive barriers including capital requirements, manufacturer relationships, and pharmacy customer relationships.
Cardinal Health agreed to pay approximately $6 billion as part of $26 billion 'Big Three' distributor settlement (2021) plus state pharmaceutical opioid claims, addressing allegations that pharmaceutical distributors failed to monitor and report suspicious opioid orders fueling the opioid epidemic that has caused 600,000+ overdose deaths since 2000. The settlement structure provided 18-year payment schedule reducing annual financial impact to manageable $300-400 million annually, plus operational changes including enhanced controlled substance monitoring systems and ordering controls. The opioid liability significantly affected Cardinal's strategic flexibility for the decade requiring settlement payments, reduced capital available for acquisitions and growth investment, and damaged company reputation requiring continued compliance and remediation focus. Healthcare distributors collectively faced over $50 billion in opioid-related settlements across various parties, demonstrating systemic accountability for opioid epidemic supply chain failures.
Cardinal Health lost its major pharmaceutical distribution contract with OptumRx (UnitedHealth subsidiary) in early 2024 — approximately $18 billion in annual revenue representing one of the largest individual contracts in pharmaceutical distribution history, with the contract transitioning to McKesson over 2024-2025. The loss reflected OptumRx's strategic decision to consolidate distribution relationships and McKesson's competitive bidding for the contract, though Cardinal Health management cited unfavorable contract economics that made retention undesirable. The contract loss reduced Cardinal Health's revenue by approximately $18 billion annually with corresponding profit impact of $400-500 million, though the lost contract may have been low-margin. Strategic response includes pursuing other large customer contracts, expanding specialty pharmacy services, and operational efficiency improvements to offset lost volume. The contract demonstrates customer concentration risk in pharmaceutical distribution and Cardinal's vulnerability to losing major customers.
Cardinal Health, headquartered in Dublin, Ohio and ranked roughly 14th on the Fortune 500 with about $222.6 billion in fiscal 2024 revenue, was a downstream casualty of the February 21, 2024 ransomware attack on UnitedHealth Group's Change Healthcare clearinghouse. Change processes roughly one in three US patient claims, and its multi-week outage forced Cardinal's specialty pharmacy and hospital customers to switch to manual prior-authorisation and billing workflows that depressed order flow into Cardinal's distribution network during the third fiscal quarter. CFO Aaron Alt told investors in May 2024 that the disruption shaved a small but measurable amount off pharmaceutical-segment profit, and the company added staff to its customer-service centres to triage payment delays. Cardinal also accelerated investments in its own cybersecurity posture, expanding its Resilience program after the 2023 MOVEit file-transfer breach exposed certain employee data and naming a new chief information security officer to report directly to CEO Jason Hollar. The episodes pushed Cardinal to diversify its enterprise IT vendors away from single points of failure, harden its OptifreightLogistics and Pyxis dispensing platforms against ransomware, and re-underwrite its cyber insurance limits ahead of the 2025 renewal. The combined response, alongside the OptumRx contract loss disclosed in 2023 and effective in mid-2024, set the stage for Cardinal's August 2024 acquisition of Specialty Networks for $1.115 billion to rebuild specialty distribution volume.